News & events

  • Vectalys receives the Seal of Excellence from the European Commission

    We are proud to announce that Vectalys has been awarded a Seal of Excellence certificate from the European commission as a result of its Horizon 2020 application.
  • Bioproduction des immunothérapies en France

    Pascale Bouillé, CEO of Vectalys and president at FlashCell, was at the "Bioproduction des immunothérapies en France" conference at Biocitech Romainville on 09-26-2017 to talk about our new generation of RNA delivery particle and its applications in gene editing and immunotherapy.
  • Upcoming ESGCT 2017 in Berlin

    The FlashCell team looks forward to sharing its recent data about LentiFlash™ for genome-editing and immunotherapy approaches at the ESGCT 2017.